Withus Pharmaceutical (330350) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Withus Pharmaceutical (330350) reported revenue of 106.4 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025106.4 billion KRW5.7 billion KRW5.0 billion KRW[source]
2024102.7 billion KRW5.7 billion KRW4.8 billion KRW[source]
202380.1 billion KRW7.9 billion KRW8.0 billion KRW[source]
202264.7 billion KRW4.9 billion KRW2.5 billion KRW[source]
202157.4 billion KRW4.9 billion KRW4.3 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025136.6 billion KRW38.6 billion KRW98.0 billion KRW[source]
2024134.7 billion KRW41.6 billion KRW93.1 billion KRW[source]
2023130.8 billion KRW40.5 billion KRW90.3 billion KRW[source]
2022119.4 billion KRW36.4 billion KRW83.0 billion KRW[source]
2021119.0 billion KRW38.1 billion KRW80.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice